CLINICAL_TRIALS
trial_result
· 2020-12-30
Clinical Trial Update: Study of Efficacy and Safety of Secukinumab in Patients With Ankylosing Spondylitis [Phase 3]
Summary
Phase 3 study of secukinumab in Ankylosing Spondylitis completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Ankylosing Spondyloarthritis | Phase 3 | Status: COMPLETED | Results posted: 2020-12-30